Hurricane season has begun: are you ready?
(HealthDay)—As Hurricane Arthur threatens the East Coast of the United States, people are getting an important reminder about safety preparations they need to make for hurricane season.
Jul 3, 2014
0
0
(HealthDay)—As Hurricane Arthur threatens the East Coast of the United States, people are getting an important reminder about safety preparations they need to make for hurricane season.
Jul 3, 2014
0
0
Federal health officials are warning consumers who use popular anti-acne treatments about rare but potentially deadly allergic reactions that can cause swelling of the face and difficulty breathing.
Jun 25, 2014
0
0
For several years, JDRF-funded researchers at the University of Virginia Center for Diabetes Technology have been hard at work designing an artificial pancreas system that would allow individuals with type 1 diabetes (T1D) ...
Jun 23, 2014
0
0
The public will have more time to weigh in on a federal proposal to regulate electronic cigarettes and other tobacco products.
Jun 21, 2014
0
0
Food companies and restaurants could soon face government pressure to make their foods less salty—a long-awaited federal effort to try to prevent thousands of deaths each year from heart disease and stroke.
Jun 17, 2014
1
0
(HealthDay)—Pregnant or breast-feeding women should increase their weekly consumption of fish, choosing types lower in mercury, according to new advice issued Tuesday by the U.S. Food and Drug Administration and the U.S. ...
Jun 10, 2014
0
0
By unleashing the immune system to attack skin cancer, researchers have made important strides against melanoma, according to the results of three clinical trials released Monday.
Jun 2, 2014
0
0
A nonprescription version of Nexium, the most popular medicine for frequent, severe heartburn, has just gone on sale.
May 27, 2014
0
6
The Food and Drug Administration has approved a new antibiotic from Durata Therapeutics to treat adults with common skin infections often acquired in U.S. hospitals.
May 23, 2014
0
0
Pfizer Inc. says the Food and Drug Administration will let the drugmaker apply for approval of its heavily touted experimental breast cancer medicine based on midstage patient testing results.
May 16, 2014
0
0